XML 44 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments and Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
Fair Value of Financial Instruments
We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.
We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).
The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.
We did not have any Level 3 financial instruments recognized in our balance sheet as of March 31, 2022 and December 31, 2021. There were no transfers between levels as of March 31, 2022 and December 31, 2021.
Fair Value Measurements on a Recurring Basis
The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March 31, 2022 and December 31, 2021.
(in millions)
Level 1
Level 2
Total
March 31, 2022
Cash equivalents:
Money market mutual funds$4 $ $4 
U.S. treasuries
   
Total cash equivalents
4  4 
Investments:
Asset-backed securities
 45 45 
Corporate bonds
 137 137 
U.S. government agencies and government-sponsored agencies
 2 2 
U.S. treasuries
 127 127 
Other debt securities
 8 8 
Total investments
 319 319 
Restricted cash equivalents:
Money market mutual funds
90  90 
U.S. treasuries 4 4 
Total restricted cash equivalents
90 4 94 
Restricted investments:
Corporate bonds 29 29 
U.S. government agencies and government-sponsored agencies 13 13 
   U.S. treasuries 175 175 
Certificate of deposit
 11 11 
Total restricted investments
 228 228 
Total cash equivalents and investments and restricted cash equivalents and investments$94 $551 $645 
(in millions)Level 1Level 2Total
December 31, 2021
Cash equivalents
Money market mutual funds$$— $
U.S. treasuries— 21 21 
Total cash equivalents21 25 
Investments
Asset-backed securities— 49 49 
Corporate bonds— 137 137 
U.S. government agencies and government-sponsored agencies— 
U.S. treasuries— 106 106 
Other debt securities— 
Total investments— 303 303 
Restricted cash equivalents:
Money market mutual funds93 — 93 
Certificate of deposit— 
Total restricted cash equivalents93 94 
Restricted investments:
Corporate bonds— 30 30 
U.S. government agencies and government-sponsored agencies— 15 15 
U.S. treasuries— 179 179 
Certificate of deposit— 11 11 
Total restricted investments— 235 235 
Total investments and restricted cash equivalents and investments$97 $560 $657 
Fair Value of Financial Instruments Disclosure
Long-Term Debt
The fair value of our 2029 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the senior notes is considered Level 2 in the hierarchy for fair value measurement. As of March 31, 2022, Our 2029 Notes were carried at their cost, net of issuance costs, and had a fair value of $463 million and $500 million as of March 31, 2022 and December 31, 2021, respectively.